The latest price target for Blend Labs (NYSE:BLND) was reported by Canaccord Genuity on May 15, 2026. The analyst firm set a price target for $4.50 expecting BLND to rise to within 12 months (a possible 179.50% upside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Blend Labs (NYSE:BLND) was provided by Canaccord Genuity, and Blend Labs maintained their buy rating.

The last upgrade for Blend Labs Inc happened on August 12, 2024 when Canaccord Genuity raised their price target to $4.75. Canaccord Genuity previously had a hold for Blend Labs Inc.

There is no last downgrade for Blend Labs.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Blend Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Blend Labs was filed on May 15, 2026 so you should expect the next rating to be made available sometime around May 15, 2027.

While ratings are subjective and will change, the latest Blend Labs (BLND) rating was a maintained with a price target of $5.25 to $4.50. The current price Blend Labs (BLND) is trading at is $1.61, which is out of the analyst’s predicted range.